Sentinel lymph node biopsy should be considered for clinically node-negative breast cancer regardless of BRCA1/2 mutation status
@article{ATM52461, author = {Xin Huang and Jia-Qi Liu and Yi-Dong Zhou and Ying Xu and Chang Chen and Xiang Wang and Xi Cao and Ru Yao and Qiang Sun}, title = {Sentinel lymph node biopsy should be considered for clinically node-negative breast cancer regardless of BRCA1/2 mutation status}, journal = {Annals of Translational Medicine}, volume = {8}, number = {18}, year = {2020}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/52461} }